Sanofi Fined $53M In France Over Generic Plavix Smears

By Daniel Wilson (May 14, 2013, 1:27 PM EDT) -- France's antitrust regulator has fined Sanofi SA €40.6 million ($52.7 million) after ruling the drugmaker had engaged in a campaign to discourage doctors and pharmacists from prescribing or substituting generic versions of its former blockbuster blood thinner Plavix, the watchdog announced Tuesday....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!